Navigation Links
Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
Date:10/23/2008

lly appreciated until recently, researchers now know that one of the major ways in which nitric oxide influences heart function is by activating the main calcium channel in the heart to release calcium from intracellular stores. Calcium is the primary determinant of contractility in the heart. A deficiency in nitric oxide disrupts the calcium cycle, inhibits heart contractility, and ultimately causes the heart to fail.

In addition to helping to elucidate a biologic basis of heart failure, Dr. Stamler has developed and tested new therapeutic modalities to preserve and improve cardiac function. He is one of the inventors of the patents underlying the drug portfolio that includes CDP-1050, which Duska recently licensed from Duke University and Johns Hopkins University.

CDP-1050 is an investigational drug candidate for the treatment of heart failure. The drug is designed to correct nitric oxide and redox imbalance in the failing heart and the cardiovascular system. CDP-1050 has a dual mechanism of action to inhibit the creation of excessive reactive oxygen radicals and restore nitric oxide to physiologic levels. The principal therapeutic target is the ryanodine receptor, the main ion channel in the heart that supplies the calcium necessary for the heart to contract. CDP-1050 is expected to enter a Phase 2 clinical study early next year.

"With its strong scientific underpinnings and commercial orientation, the Duska team is the perfect group to organize and manage the CDP-1050 Phase 2 proof-of-concept study in heart failure patients," Dr. Stamler commented. "CDP-1050 is pioneering a new paradigm of heart failure treatments by directly repairing molecular damage to the heart, the root cause of heart failure."

"Dr. Stamler has developed proprietary investigational drugs for heart failure based on his comprehensive and profound understanding of the signal transduction defects underlying the disease. We believe that his formal involvement with Dus
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
2. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
3. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
4. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
5. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
6. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
7. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
8. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
9. iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
10. Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV
11. Leading Lobbying Firm Celebrates Growth and New Name: Troutman Sanders Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... August 01, 2014 Once a decision ... cost? This webinar will discuss how to define your ... Join speakers Bob Allen, Senior Director of Facilities Integration ... Engineering at Fluor Industrial Services, and special guest Carrier ... Planning at Amgen, as they provide an examination of ...
(Date:8/1/2014)... Aug. 1, 2014 Glencoe Software, ... of "Data InPress" ( http://glencoesoftware.com/data-inpress.html ), a ... multidimensional image data into on-line publications.  The ... Video Injection Service. Photo - ... http://photos.prnewswire.com/prnh/20140731/132409 The DataViewer ...
(Date:7/31/2014)... “2014 Deep Research Report ... is a professional and in-depth research report ... Polyurethane Resin basic information, including its definition, ... industry overview. This research covers the international ... well as global industry analysis covering macroeconomic ...
(Date:7/31/2014)... not donor candidates for bone marrow transplantation. The immune ... prone to life-threatening infection and other maladies, and a ... reason why. , "We have found the cellular mechanism ... blood production over time in an old organism, and ... rejuvenation therapies," said Emmanuelle Passegu, PhD, a professor of ...
Breaking Biology Technology:Defining Low Cost in Your Solution for Future Facilities, New Webinar for Pharma, Biotech, Medical Device and Healthcare Companies, Hosted by Xtalks 2Glencoe Software Launches Data InPress 2Glencoe Software Launches Data InPress 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 4Key to aging immune system is discovered 2
... Ill., Sept. 17 Baxter,International (NYSE: BAX ), ... quarter 2008 financial results on Thursday, October 16, 2008, ... access the call, please,dial 866- 238-0637 (domestic) or 703-639-1156 ... prior to the start of the call for the,operator ...
... (Amex: SYI ) today announced that a Letter ... http://www.synvista.com . The,text is as follows:, To ... made tremendous progress in our,efforts to deliver on the ... cardiovascular disease in diabetics as well as the,treatment of ...
... a systems,biology company focused on identifying molecular mechanisms, ... molecular diagnostics,announced today that it has appointed Louis ... executive management team, Mr. Latino will lead the,company,s ... sales,infrastructure to drive future growth., In his ...
Cached Biology Technology:Baxter International Third Quarter 2008 Financial Results Conference Call 2Synvista Therapeutics Posts Letter to Stockholders on Web Site 2Synvista Therapeutics Posts Letter to Stockholders on Web Site 3Synvista Therapeutics Posts Letter to Stockholders on Web Site 4Synvista Therapeutics Posts Letter to Stockholders on Web Site 5Synvista Therapeutics Posts Letter to Stockholders on Web Site 6Genstruct Names Louis Latino VP of Sales 2Genstruct Names Louis Latino VP of Sales 3
(Date:8/1/2014)... been recorded into the Reptile Database, a web-based ... making the reptile species among the most diverse ... fish species. , For some time, experts have ... reptiles would become the most diverse vertebrate group ... crocodiles, tuataras and amphisbaenians. , "Officially, we have ...
(Date:8/1/2014)... Professor Charan Ranganath of the UC Davis Center ... a National Security Science and Engineering Faculty Fellowship ... $2.6 million fellowship will support new work on ... at UC Davis. , The new project aims ... understood, with activity in the cortex and hippocampus, ...
(Date:8/1/2014)... confused group of marine mammals have officially named ... dolphin, Sousa sahulensis , according to the ... The study describing the newly named species is ... of all available historical records, physical descriptions, and ... coastal cetaceans ranging from the coast of West ...
Breaking Biology News(10 mins):Reptile Database surpasses 10,000 reptile species 2Reptile Database surpasses 10,000 reptile species 3Scientists name new species of cetacean: The Australian humpback dolphin 2Scientists name new species of cetacean: The Australian humpback dolphin 3
... The Howard Hughes Medical Institute (HHMI) and the Gordon ... Martienssen, Ph.D., of Cold Spring Harbor Laboratory (CSHL) to ... fundamental plant science. Dr. Martienssen is one of 15 ... been named HHMI-GBMF Investigators in plant sciences. ...
... uncovered the defect behind a rare hereditary children,s disease ... D. This discovery has led researchers to develop the ... disease. Idiopathic Infantile Hypercalcemia (IIH) is among the ... that one in every 47,000 people around 600 ...
... the U.S. biomedical device industry unveiled today a national ... development of devices with great clinical utility, quality and ... key component of the nation,s drive to bolster its ... device innovation that improves human health, the leaders said. ...
Cached Biology News:CSHL professor Rob Martienssen receives prestigious appointment as HHMI-GBMF investigator 2CSHL professor Rob Martienssen receives prestigious appointment as HHMI-GBMF investigator 3CSHL professor Rob Martienssen receives prestigious appointment as HHMI-GBMF investigator 4U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 2U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 3U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering" 4
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
... and SYBR Safe DNA Gel Stain combo offers these ... buying these same products separately ... bromide Eliminates risks to ... and RNA fragments from 100 bp to >30 kb. ...
Anti-WT-1 Liquid. In 10 μM PBS, 0.2 % BSA, pH 7.6. Recognizes the ~47-55 kDa Wilm's tumor protein in Wilm's tumor tissue. ...
... The economical ICS-90 uses continuous chemical ... to give you fast, accurate determinations of ... ranges. Easy to operate, quick to equilibrate, ... the compact ICS-90 helps you achieve maximum ...
Biology Products: